Publication | Open Access

Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer

Breast OncologyEstrogen Receptor ModulatorMedicinePathologyAdjuvant TamoxifenBreast CancerCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentEndocrine-related Cancer